Entero Healthcare Solutions Limited has incorporated a new step-down subsidiary company named Qurovia Lifesciences Private Limited.

The company received intimation of the incorporation on July 31, 2026, under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Subsidiary Details

  • Name: Qurovia Lifesciences Private Limited (Qurovia)
  • Date of Incorporation: July 25, 2026
  • Country of Incorporation: India
  • Certificate of Incorporation: Received from Ministry of Corporate Affairs on July 31, 2026, at 12:05 p.m.

Ownership Structure

Qurovia is incorporated as a wholly owned subsidiary of R S M Pharma Private Limited (RSM). Since RSM is a wholly owned subsidiary of Entero Healthcare Solutions Limited, Qurovia becomes a step-down subsidiary of the company.

Business Operations

  • Industry: Wholesale and Retail Distribution of Pharmaceuticals and Healthcare Products
  • Business Scope: Marketing, distribution, import, export, wholesale and retail of pharmaceuticals, healthcare products and services, medical devices, diagnostics, healthcare technologies, and allied healthcare activities

Regulatory Approvals

No governmental or regulatory approvals were required for the incorporation.

Financial Details

  • Consideration Type: Cash consideration
  • Authorized Share Capital: ₹1,50,00,000 (Rupees One Crore Fifty Lakh)
  • Share Structure: 15,00,000 equity shares of ₹10 (Rupees Ten) each
  • Initial Subscription: RSM along with its nominee subscribed to 10,000 equity shares of ₹10 each
  • Total Subscription Amount: ₹1,00,000 (Rupees One Lakh)

Ownership Percentage

Qurovia is incorporated as a wholly owned subsidiary of R S M Pharma Private Limited, making it a step-down wholly owned subsidiary of Entero Healthcare Solutions Limited.

Additional Information

The disclosure is made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Para-A of Part-A of SCHEDULE III and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

The information will be available on the company's website at www.enterohealthcare.com.